Affecting height outcomes in children with precocious puberty

Pediatric Endocrinology Reviews

Volumn 4, Issue SUPPL. 3, 2007, Pages 283-290

  Klein, Karen Oerter ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

Final height; Height outcome; Precocious puberty; Treatment duration

Indexed keywords

GONADORELIN;

BONE AGE; HEIGHT; HEREDITY; HUMAN; ONSET AGE; OUTCOME ASSESSMENT; PRECOCIOUS PUBERTY; PUBERTY; REVIEW; SIDE EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

EID: 34250199749     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Kaplan SL, Grumbach MM. Clinical Review. 14: Pathophysiology and treatment of sexual precocity. J Clin Endocrinol Metab 1990;71:785-789
2. Conn PM, Crowley WF. Gonadotropin-releasing hormone and its analogs. Annu Rev Med 1994;45:391-405
3. Kappy MS, Ganong CS. Advances in the treatment of precocious puberty. Adv Pediatr 1994;41:223-261
4. Virdis R, Sigorini M, Laiolo A, Lorenzetti E, Street ME, Villani AR, Donadio A, Pisani F, Terzi C, Garavelli L. Neurofibromatosis type 1 and precocious puberty. J Pediatr Endocrinol Metab 2000;13(Suppl 1):841-844
5. Micillo M, Salerno M, Officioso A, Perna E, Gasparini N, Pisaturo L, Di Maio S. Near final height after GnRH agonist treatment in central precocious puberty. J Pediatr Endocrinol Metab 2000;13(Suppl 1):787-790
6. Oerter KE, Manasco P, Barnes KM, Jones J, Hill S, Cutler GB Jr. Adult height in precocious puberty after long-term treatment with deslorelin. J Clin Endocrinol Metab 1991;73:1235-1240
7. Kauli R, Galatzer A, Kornreich L, Lazar L, Pertzelan A, Laron Z. Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue: a comparative study with re-evaluation of predictions by the Bayley-Pinneau method. Horm Res 1997;47:54-61
8. Oostdijk W, Rikken B, Schreuder S, Otten B, Odink R, Rouwe C, Jansen M, Gerver WJ, Waelkens J, Drop S. Final height in central precocious puberty after long term treatment with a slow release GnRH agonist. Arch Dis Child 1996;75:292-297
9. Bertelloni S, Baroncelli GI, Ferdeghini M, Menchini-Fabris F, Saggese G. Final height, gonadal function and bone mineral density of adolescent males with central precocious puberty after therapy with gonadotropin-releasing hormone analogues. Eur J Pediatr 2000;159:369-374
10. Rizzo V, De Sanctis V, Corrias A, Fortini M, Galluzzi F, Bertelloni S, Guarneri MP, Pozzan G, Cisternino M, Pasquino AM. Factors influencing final/near-final height in 12 boys with central precocious puberty treated with gonadotropin-releasing hormone agonists. Italian study group of physiopathology of puberty. J Pediatr Endocrinol Metab 2000;13(Suppl 1):781-786
11. Antoniazzi F, Arrigo T, Cisternino M, Galluzzi F, Bertelloni S, Pasquino AM, Borrelli P, Osio D, Mengarda F, De Luca F, Tato L. End results in central precocious puberty with GnRH analog treatment: The data of the Italian study group for physiopathology of puberty. J Pediatr Endocrinol Metab 2000;13:773-780
12. Brown JJ, Warne GL. Growth in precocious puberty. Indian J Pediatr 2006;73:81-88
13. Thamdrup E. Precocious sexual development. A clinical study of 100 children. Copenhagen; Munksgaard 1961;104-105
14. Sigurjonsdottir TJ, Hayles AB. Precocious puberty. A report of 96 cases. Am J Dis Child 1968;115(3):309-321
15. Bovier-Lapierre M, Sempe M, David M. (Etiological, clinical and biological aspects of precocious puberty of central origin) Pediatrie 1972;27(6):587-609
16. Werder EA, Murset G, Zachmann M, Brook CG, Prader A. Treatment of precocious puberty with cyproterone acetate. Pediatr Res 1974;8(4):248-256
17. Lee PA. Medroxyprogesterone therapy for sexual precocity in girls. Am J Dis Child 1981;135(5):443-445
18. Schoevaart CE, Drop SL, Otten BJ, Slijper FM, Degenhart HJ. Growth analysis up to final height and psychosocial adjustment of treated and untreated patients with precocious puberty. Horm Res 1990;34(5-6):197-203
19. Paul D, Conte FA, Grumbach MM, Kaplan SL. Long-term effect of gonadotropin-releasing hormone agonist therapy on final and near-final height in 26 children with true precocious puberty treated at a median age of less than 5 years. J Clin Endocrinol Metab 1995;80(2):546-551
20. Kauli R, Kornreich L, Laron Z. Pubertal development, growth and final height in girls with sexual precocity after therapy with the GnRH analogue D-TRP-6-LHRH. A report on 15 girls, followed after cessation of gonadotrophin suppressive therapy. Horm Res 1990;33(1):11-17
21. Brauner R, Adan L, Malandry F, Zantleifer D. Adult height in girls with idiopathic true precocious puberty. J Clin Endocrinol Metab 1994;79(2):415-420
22. Antoniazzi F, Cisternino M, Nizzoli G, Bozzola M, Corrias A, De Luca F, De Sanctis C, Rigon F, Zamboni G, Bernasconi S. Final height in girls with central precocious puberty: comparison of two different luteinizing hormone-releasing hormone agonist treatments. Acta Paediatr 1994;83(10):1052- 1056
23. Bertelloni S, Baroncelli GI, Sorrentino MC, Perri G, Saggese G. Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females. Eur J Pediatr 1998;157(5):363-367
24. Galluzzi F, Salti R, Bindi G, Pasquini E, La Cauza C. Adult height comparison between boys and girls with precocious puberty after long-term gonadotrophin-releasing hormone analogue therapy. Acta Paediatr 1998;87(5):521-527
25. Arrigo T, Cisternino M, Galluzzi F, Bertelloni S, Pasquino AM, Antoniazzi F, Borrelli P, Crisafulli G, Wasniewska M, De Luca F. Analysis of the factors affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty. Eur J Endocrinol 1999;141(2):140-144
26. Carel JC, Chaussain JL. Gonadotropin releasing hormone agonist treatment for central precocious puberty. Horm Res 1999;51(Suppl 3):64-69
27. Cassio A, Cacciari E, Balsamo A, Bal M, Tassinari D. Randomised trial of LHRH analogue treatment on final height in girls with onset of puberty aged 7.5-8.5 years. Arch Dis Child 1999;81(4):329-332
28. Heger S, Partsch CJ, Sippell WG. Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function. J Clin Endocrinol Metab 1999;84(12):4583-4590 Erratum in: J Clin Endocrinol Metab 2000;85(2):657
29. Mul D, Oostdijk W, Otten BJ, Rouwe C, Jansen M, Delemarre-van de Waal HA, Waelkens JJ, Drop SL. Final height after gonadotrophin releasing hormone agonist treatment for central precocious puberty: the Dutch experience. J Pediatr Endocrinol Metab 2000;13(Supp 1):765-772
30. Leger J, Reynaud R, Czernichow P. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment? J Pediatr 2000;137(6):819-825
31. Klein KO, Barnes KM, Jones JV, Feuillan PP, Cutler GB Jr. Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience. J Clin Endocrinol Metab 2001;86(10):4711-4716
32. Adan L, Chemaitilly W, Trivin C, Brauner R. Factors predicting adult height in girls with idiopathic central precocious puberty: implications for treatment. Clin Endocrinol (Oxf) 2002;56(3):297-302
33. Rizzo V, De Sanctis V, Corrias A, Fortini M, Galluzzi F, Bertelloni S, Guarneri MP, Pozzan G, Cisternino M, Pasquino AM. Factors influencing final/near-final height in 12 boys with central precocious puberty treated with gonadotrophin-releasing hormone agonists. Italian Study Group of Physiopathology of Puberty. J Pediatr Endocrinol Metab 2000;13(Suppl 1):781-786
34. Cataldo F, Accomando S, Porcari V. Internationally adopted children: a new challenge for pediatricians. Minerva Pediatr 2006;58(1):55-62
35. Gluckman PD, Hanson MA. Evolution, development and timing of puberty. Trends Endocrinol Metab 2006;17(1):7-12
36. Mul D, Fredriks AM, van Buuren S, Oostdijk W, Verloove-Vanhorick SP, Wit JM. Pubertal development in The Netherlands 1965-1997. Pediatr Res 2001;50(4):479-486
37. Kaplowitz PB, Slora EJ, Wasserman RC, Pedlow SE, Herman-Giddens ME. Earlier onset of puberty in girls: relation to increased body mass index and race. Pediatrics 2001;108(2):347-353
38. Fontoura M, Brauner R, Prevot C, Rappaport R. Precocious puberty in girls: early diagnosis of a slowly progressing variant. Arch Dis Child 1989;64:1170-1176
39. Kreiter M, Burstein S, Rosenfield RL, Moll GW Jr, Cara JF, Yousefzadeh DK, Cuttler L, Levitsky LL. Preserving adult height potential in girls with idiopathic true precocious puberty. J Pediatr 1990;117:364-370
40. Palmert MR, Malin HV, Boepple PA. Unsustained or slowly progressive puberty in young girls: initial presentation and long-term follow-up of 20 untreated patients. J Clin Endocrinol Metab 1999;84(2):415-423
41. Bouvattier C, Coste J, Rodrigue D, Teinturier C, Carel JC, Chaussain JL, Bougneres PF. Lack of effect of GnRH agonists on final height in girls with advanced puberty: a randomized long-term pilot study. J Clin Endocrinol Metab 1999; 84:3575-3578
42. Kletter GB, Kelch RP. Clinical review 60: effects of gonadotropin- releasing hormone analog therapy on adult stature in precocious puberty. J Clin Endocrinol Metab 1994;79:331-334
43. Partsch CJ, Heger S, Sippell WG. Treatment of central precocious puberty: lessons from a 15 years prospective trial. German Decapeptyl Study Group. J Pediatr Endocrinol Metab 2000;13(Suppl 1):747-758
44. Carel JC, Roger M, Ispas S, Tondu F, Lahlou N, Blumberg J, Chaussain JL. Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment. French study group of Decapeptyl in Precocious Puberty. J Clin Endocrinol Metab 1999;84:1973-1978
45. Micillo M, Salerno M, Officioso A, Perna E, Gasparini N, Pisaturo L, Di Maio S. Near final height after GnRH agonist treatment in central precocious puberty. J Pediatr Endocrinol Metab 2000;13(Supp 1):787-790
46. Carel JC, Lahlou N, Roger M, Chaussain JL. Precocious puberty and statural growth. Hum Reprod Update 2004;10(2):135-147
47. Lazar L, Pertzelan A, Weintrob N, Phillip M, Kauli R. Sexual precocity in boys: accelerated versus slowly progressive puberty gonadotropin-suppressive therapy and final height. J Clin Endocrinol Metab 2001;86(9):4127-4132
48. Ohyama K, Tanaka T, Tachibana K, Niimi H, Fujieda K, Matsuo N, Satoh M, Hibi I. Timing for discontinuation of treatment with a long-acting gonadotropin-releasing hormone analog in girls with central precocious puberty. Endocr J 1998;45:351-356
49. Arrigo T, Cisternino M, Galluzzi F, Bertelloni S, Pasquino AM, Antoniazzi F, Borrelli P, Crisafulli G, Wasniewska M, De Luca F. When to stop GnRH analog therapy: The experience of the Italian study group for physiopathology of puberty. J Pediatr Endocrinol Metab 2000;13:759-764
50. Yanovski JA, Rose SR, Municchi G, Pescovitz OH, Hill SC, Cassorla FG, Cutler GB Jr. Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature. N Engl J Med 2003;348:908-917
51. Cutler GB Jr, Cassorla FG, Ross JL, Pescovitz OH, Barnes KM, Comite F, Feuillan PP, Laue L, Foster CM, Kenigsberg D. Pubertal growth: physiology and pathophysiology. Recent Prog Horm Res 1986;42:443-470
52. Conte FA, Grumbach MM, Ito Y, Fisher CR, Simpson ER. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). J Clin Endocrinol Metab 1994;78:1287-1292
53. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 1994;331:1056-1061
54. Pucarelli I, Sgni M, Ortore M, Arcadi E, Pasquino AM. Effects of combined gonadotropin-releasing hormona agonist and growth hormona therapy on adult height in precocious puberty: a further contribution. J Pediatr Endocrinol Metab 2003;16:1005-1010
55. Pasquino AM, Pucarelli I, Segni M, Matrunola M, Cerrone F. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone. J Clin Endocronol Metab 1999;84:449-452
56. Lanes R, Gunczier P. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty. Clinical Endocrinol 1998;49:197-202
57. Parker KL, Baens-Bailon RG, Lee PA. Depot leuprolide acetate dosage for sexual precocity. J Clin Endocrinol Metab 1991;73(1):50-52
58. Lanes R, Soros A, Jakubowicz S. Accelerated versus slowly progressive forms of puberty in girls with precocious and early puberty. Gonadotropin suppressive effect and final height obtained with two different analogs. J Pediatr Endocrinol Metab 2004;17(5):759-766
59. Badaru A, Wilson DM, Bachrach LK, Fechner P, Gandrud LM, Durham E, Wintergerst K, Chi C, Klein KO, Neely EK. Sequential comparisons of one-month and three-month depot leuprolide regimens in central precocious puberty. J Clin Endocrinol Metab 2006;91(5):1862-1867
60. Rizzo V, De Sanctis V, Corrias A, Fortini M, Galluzzi F, Bertelloni S, Guarneri MP, Pozzan G, Cisternino M, Pasquino AM. Factors influencing final/near-final height in 12 boys with central precocious puberty treated with gonadotrophin-releasing hormone agonists. Italian Study Group of Physiopathology of Puberty. J Pediatr Endocrinol Metab 2000;13(Suppl 1):781-786